Ginkgo Bioworks Unit Zymergen Filed for Chapter 11 Bankruptcy

Oct. 3, 2023, 11:12 AM UTC

Ginkgo Bioworks unit Zymergen filed for Chapter 11 bankruptcy in Delaware. Neither Ginkgo nor other subsidiaries are filing for bankruptcy protection.

  • Ginkgo ended the second quarter of 2023 with $1.1 billion of cash and cash equivalents
  • Ginkgo entered into an asset purchase agreement with Zymergen as the stalking horse bidder to acquire exclusive rights to substantially all of Zymergen’s intellectual property assets and certain other assets
    • Ginkgo’s bid includes a $5 million cash component and assumption of up to $77 million of potential future liabilities, including a lease

To view the source of this information, click here

To contact the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.